Jul 9, 2026 7:05 am EDT NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
Jun 17, 2026 6:00 am EDT NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
Jun 15, 2026 5:24 pm EDT NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
Apr 23, 2026 7:05 am EDT NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
Apr 13, 2026 7:05 am EDT NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
